Genetics and Beyond: The Need for Mega-Biobanks in Chronic Disease Research







Swiss Tropical and Public Health Institute

Prof. Dr. Nicole Probst-Hensch, Head Unit Chronic Disease Epidemiology

The 2012 edition of the Life Science Forum Basel took place on June 21st 2012 at the Bio/Pharmazenrum Basel

Key Note presentation by Prof. Brian Smith

Pragmedic







The Future of Pharma: Evolutionary Threats and Opportunities

Market Access of Medicinal Products in the Commonwealth of Independent states (CIS)...

...and will the Mafia come to your hotel room to kill you?




Tricom GmbH

Dr David J. Smith

Legal Challenges of doing business in Emerging Markets




Varian Medical Systems

Christian Matton, Legal


Director Europe, CIS,

Middle East, Africa & India

Role of Health Economics in Product Development and Commercialization




Rudolf Virchow Institut

Fred Sorenson, Director of Operations

The Future of Pharma:

Evolutionary Threats and Opportunities

To compare the incomparable



Department of Nuclear Medicine, University Hospital


Bern, Dr. Thilo Weitzel

The AOCSC Learning Experience on How to Conduct Standardized Clinical Studies in 10 Countries and 20 Clinics.






AO Clinical Investigation and Documentation,

Diarmuid De Faoite, Business Developer

Managing Anti-Corruption Efforts in the New Era of Enforcement






MetricStream, Christopher Cieslok

Director Business Operations Europe

Maximising the value of clinical data for new markets and moving opportunities




Oracle Health Sciences

Srinivas Karri, Principal Consultant